The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II, randomized, double-blind, placebo-controlled trial evaluating efficacy and safety of namodenoson (CF102), an A3 adenosine receptor agonist (A3AR), as a second-line treatment in patients with Child-Pugh B (CPB) advanced hepatocellular carcinoma (HCC).
 
Salomon M. Stemmer
Stock and Other Ownership Interests - canfite; CTG Pharma; DocBoxMD; tyrnovo; VYPE
Consulting or Advisory Role - Novartis
Research Funding - AstraZeneca (Inst); BiolineRx (Inst); Bristol-Myers Squibb (Inst); Can-Fite BioPharma (Inst); Clovis Oncology (Inst); CTG Pharma (Inst); Exelixis (Inst); Geicam (Inst); Halozyme (Inst); Incyte (Inst); Lilly (Inst); Moderna Therapeutics (Inst); MSD (Inst); Puma Biotechnology (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Silenseed (Inst); SynCoreBio (Inst); Teva (Inst); Tiziana Life Sciences (Inst)
Travel, Accommodations, Expenses - Genomic Health
 
Nebojsa S. Manojlovic
No Relationships to Disclose
 
Mihai Vasile Marinca
No Relationships to Disclose
 
Petar Petrov
No Relationships to Disclose
 
Nelly Cherciu
No Relationships to Disclose
 
Doina Ganea
No Relationships to Disclose
 
Tudor-Eliade Ciuleanu
No Relationships to Disclose
 
Ioana Adriana Puscas
No Relationships to Disclose
 
Muhammad Shaalan Beg
Consulting or Advisory Role - Boston Biomedical; Celgene; Genentech/Roche; Guardant Health; Ipsen
Speakers' Bureau - Bristol-Myers Squibb; Genentech/Roche; Ipsen
Research Funding - Agios (Inst); ArQule (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); CASI Pharmaceuticals (Inst); Celgene (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); MedImmune (Inst); Merck Serono (Inst); Sillajen (Inst); Tolero Pharmaceuticals (Inst)
 
William T. Purcell
No Relationships to Disclose
 
Adina-Emilia Croitoru
Consulting or Advisory Role - Amgen; Bayer; Ipsen; Lilly; Merck Serono; Novartis; Pfizer; Roche; Sandoz; Sanofi/Aventis
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Canfite; Canfite (Inst); Gilead Sciences; Gilead Sciences (Inst); Merck Serono; Merck Serono (Inst); NanoCarrier; NanoCarrier (Inst); Pfizer; Pfizer (Inst)
Travel, Accommodations, Expenses - Acraf; Amgen; Genekor; Merck Serono; Pfizer; Sandoz
 
Rumyana Nedyalkova Ilieva
No Relationships to Disclose
 
Sladjana Natošević
No Relationships to Disclose
 
Amedeia Lavinir Nita
No Relationships to Disclose
 
Dimitar Nikolaev Kalev
No Relationships to Disclose
 
Zivit Harpaz
Employment - Can-Fite BioPharma
Leadership - Can-Fite BioPharma
Stock and Other Ownership Interests - Can-Fite BioPharma
Travel, Accommodations, Expenses - Can-Fite BioPharma
 
Motti Farbstein
Employment - Can-Fite BioPharma
Leadership - Can-Fite BioPharma
Stock and Other Ownership Interests - Can-Fite BioPharma
Patents, Royalties, Other Intellectual Property - Can-Fite BioPharma
Travel, Accommodations, Expenses - Can-Fite BioPharma
 
Michael H. Silverman
Employment - Can-Fite BioPharma
Leadership - Can-Fite BioPharma (I)
Stock and Other Ownership Interests - Can-Fite BioPharma
Consulting or Advisory Role - Can-Fite BioPharma
Travel, Accommodations, Expenses - Can-Fite BioPharma
 
Pnina Fishman
Employment - Can-Fite BioPharma
Leadership - Can-Fite BioPharma
Stock and Other Ownership Interests - Can-Fite BioPharma
Consulting or Advisory Role - Can-Fite BioPharma (Inst)
Research Funding - Can-Fite BioPharma
Patents, Royalties, Other Intellectual Property - Can-Fite BioPharma
Travel, Accommodations, Expenses - Can-Fite BioPharma
 
Josep M Llovet
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Celsion; Eisai; Exelixis; Glycotest; Incyte; Lilly
Research Funding - Bayer Schering Pharma (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst)
Travel, Accommodations, Expenses - Bayer